Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells
- PMID: 8253864
- DOI: 10.1002/jcp.1041570312
Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells
Abstract
Osteoblasts secrete transforming growth factor beta (TGF beta) as a biologically inert, latent complex that must be dissociated before the growth factor can exert its effects. We have examined the production and proteolytic activation of latent TGF beta (LTGF beta) by clonal UMR 106-01 rat osteosarcoma cells and neonatal mouse calvarial (MC) osteoblast-like cells in vitro. Synthetic bPTH-(1-34) increased the activity of tissue-type (tPA) and urokinase-type (uPA) plasminogen activators (PA) in cell lysates (CL) of UMR 106-01 cells. The concentration of active TGF beta in serum-free CM from cultures treated with bPTH-(1-34) and plasminogen was significantly greater than in CM from untreated controls and cultures treated with either bPTH-(1-34) or plasminogen alone. This effect occurred at concentrations of PTH-(1-34) that increased PA activity and was prevented by aprotinin, an inhibitor of plasmin activity. Treatment with bPTH-(1-34) had no effect on the concentration of TGF beta in acid-activated samples of CM. Functional consequences of proteolytically activated TGF beta was examined in primary cultures of neonatal MC osteoblast-like cells. Human platelet TGF beta 1 caused a dose-dependent increase in the migration of these cells in an in vitro wound healing assay. Cell migration was also stimulated in cultures treated with bPTH-(1-34) and plasminogen together. This effect was blocked by an anti-TGF beta 1 antibody. The results of these studies demonstrate that (1) LTGF beta secreted by osteoblasts in vitro is activated under conditions where the plasmin activity in the cultures is increased, and (2) the TGF beta generated by plasmin-mediated proteolysis is biologically active. We suggest that the local concentration of TGF beta in bone may be controlled by the osteoblast-associated plasminogen activator/plasmin system. Furthermore, since several calciotropic factors influence osteoblast PA activity, this system may have an important role in mediating their anabolic and/or catabolic effects.
Similar articles
-
Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.J Cell Physiol. 1991 Oct;149(1):34-43. doi: 10.1002/jcp.1041490106. J Cell Physiol. 1991. PMID: 1834680
-
Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.J Cell Physiol. 1994 Mar;158(3):398-407. doi: 10.1002/jcp.1041580303. J Cell Physiol. 1994. PMID: 8126064
-
The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.J Bone Miner Res. 1992 Dec;7(12):1363-71. doi: 10.1002/jbmr.5650071203. J Bone Miner Res. 1992. PMID: 1481722
-
Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.Anticancer Res. 1997 May-Jun;17(3A):1461-5. Anticancer Res. 1997. PMID: 9179184 Review.
-
The plasminogen activator inhibitor system in bone cell function.Clin Orthop Relat Res. 1995 Apr;(313):54-63. Clin Orthop Relat Res. 1995. PMID: 7641498 Review.
Cited by
-
Transforming growth factor-β in tumour development.Front Mol Biosci. 2022 Oct 4;9:991612. doi: 10.3389/fmolb.2022.991612. eCollection 2022. Front Mol Biosci. 2022. PMID: 36267157 Free PMC article. Review.
-
Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.Am J Respir Cell Mol Biol. 2012 Feb;46(2):196-206. doi: 10.1165/rcmb.2011-0071OC. Am J Respir Cell Mol Biol. 2012. PMID: 22298529 Free PMC article.
-
Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.Clin Exp Metastasis. 1997 May;15(3):205-17. doi: 10.1023/a:1018413229570. Clin Exp Metastasis. 1997. PMID: 9174122
-
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.J Clin Invest. 2015 Aug 3;125(8):3117-31. doi: 10.1172/JCI80313. Epub 2015 Jul 27. J Clin Invest. 2015. PMID: 26214526 Free PMC article.
-
Tissue Plasminogen Activator: Side Effects and Signaling.J Drug Des Res. 2014 Sep 25;1(1):1001. J Drug Des Res. 2014. PMID: 25879083 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous